This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Graftech International's CEO Discusses Q1 2012 Results - Earnings Call Transcript

Also, to the extent that we discuss any non-GAAP financial measures, you will find reconciliations in our press release, which is posted on our website at in the Investor Relations Section. For your reference, a replay of the call will be available on our website.

At this time, I’d like to turn the call over to Craig.

Craig Shular

Thank you, Kelly. Good morning, everyone, and thank you for joining Graftech’s call today. Today, we’ll take you through our first quarter highlights and then open it up to questions.

In Q1, sales were 241 million, down 21% versus a year ago. As previously guided, Grafite Electrode sales were lower, largely due to customer destocking initiatives, especially in Europe where the steel market has slowed considerably in response to recessionary conditions in the region.

We believe the majority of the destocking initiatives were completed in Q1 and the balance of the destocking will be completed by mid-year.

EBITDA came in at 40 million, in line with our targeted estimate. Net income was 18 million, or $0.12 per share. We had a couple one-time benefits in the quarter. One, higher Q4 electrode utilization rates that allowed for better fixed cost absorption, which flowed through our P&L in Q1 and provided about a $0.03 benefit. And then secondly, a non-reoccurring insurance reimbursement, which provided a $0.02 benefit.

Net debt increased to 466 million, largely the result of planned increase in working capital and CapEx expenditures.

Turning to the segment, Industrial Material sales were 193 million and Operating Income came in at 25 million.

The previously-mentioned benefit resulting from higher Q4 operating rates was also a major driver of gross margin expansion in Q1, which will not be carried forward given our previously-reviewed plans to turn our Grafite Electrodes plants at approximately 70% operating rate for the balance of the year.

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.57 -0.14%
FB $101.66 -0.25%
GOOG $681.86 -0.18%
TSLA $147.78 -1.80%
YHOO $26.79 0.11%


Chart of I:DJI
DOW 15,886.31 +226.13 1.44%
S&P 500 1,852.17 +23.09 1.26%
NASDAQ 4,305.8670 +39.03 0.91%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs